262 related articles for article (PubMed ID: 23793046)
1. Detection of volatile biomarkers of therapeutic radiation in breath.
Phillips M; Byrnes R; Cataneo RN; Chaturvedi A; Kaplan PD; Libardoni M; Mehta V; Mundada M; Patel U; Ramakrishna N; Schiff PB; Zhang X
J Breath Res; 2013 Sep; 7(3):036002. PubMed ID: 23793046
[TBL] [Abstract][Full Text] [Related]
2. Breath biomarkers of whole-body gamma irradiation in the Göttingen minipig.
Phillips M; Cataneo RN; Chaturvedi A; Kaplan PD; Libardoni M; Mundada M; Patel U; Thrall KD; Zhang X
Health Phys; 2015 May; 108(5):538-46. PubMed ID: 25811151
[TBL] [Abstract][Full Text] [Related]
3. Breath biomarkers of total body irradiation in non-human primates.
Phillips M; Grun F; Schmitt P
J Breath Res; 2022 Jan; 16(2):. PubMed ID: 34781275
[No Abstract] [Full Text] [Related]
4. Volatile organic compounds (VOCs) in exhaled breath of patients with breast cancer in a clinical setting.
Mangler M; Freitag C; Lanowska M; Staeck O; Schneider A; Speiser D
Ginekol Pol; 2012 Oct; 83(10):730-6. PubMed ID: 23383557
[TBL] [Abstract][Full Text] [Related]
5. Evidence of endogenous volatile organic compounds as biomarkers of diseases in alveolar breath.
Sarbach C; Stevens P; Whiting J; Puget P; Humbert M; Cohen-Kaminsky S; Postaire E
Ann Pharm Fr; 2013 Jul; 71(4):203-15. PubMed ID: 23835018
[TBL] [Abstract][Full Text] [Related]
6. Blinded Validation of Breath Biomarkers of Lung Cancer, a Potential Ancillary to Chest CT Screening.
Phillips M; Bauer TL; Cataneo RN; Lebauer C; Mundada M; Pass HI; Ramakrishna N; Rom WN; Vallières E
PLoS One; 2015; 10(12):e0142484. PubMed ID: 26698306
[TBL] [Abstract][Full Text] [Related]
7. A volatile biomarker in breath predicts lung cancer and pulmonary nodules.
Phillips M; Bauer TL; Pass HI
J Breath Res; 2019 Jun; 13(3):036013. PubMed ID: 31085817
[TBL] [Abstract][Full Text] [Related]
8. Factors that influence the volatile organic compound content in human breath.
Blanchet L; Smolinska A; Baranska A; Tigchelaar E; Swertz M; Zhernakova A; Dallinga JW; Wijmenga C; van Schooten FJ
J Breath Res; 2017 Feb; 11(1):016013. PubMed ID: 28140379
[TBL] [Abstract][Full Text] [Related]
9. Detection of an extended human volatome with comprehensive two-dimensional gas chromatography time-of-flight mass spectrometry.
Phillips M; Cataneo RN; Chaturvedi A; Kaplan PD; Libardoni M; Mundada M; Patel U; Zhang X
PLoS One; 2013; 8(9):e75274. PubMed ID: 24086492
[TBL] [Abstract][Full Text] [Related]
10. Volatile biomarkers of pulmonary tuberculosis in the breath.
Phillips M; Cataneo RN; Condos R; Ring Erickson GA; Greenberg J; La Bombardi V; Munawar MI; Tietje O
Tuberculosis (Edinb); 2007 Jan; 87(1):44-52. PubMed ID: 16635588
[TBL] [Abstract][Full Text] [Related]
11. Profiling of volatile organic compounds in exhaled breath as a strategy to find early predictive signatures of asthma in children.
Smolinska A; Klaassen EM; Dallinga JW; van de Kant KD; Jobsis Q; Moonen EJ; van Schayck OC; Dompeling E; van Schooten FJ
PLoS One; 2014; 9(4):e95668. PubMed ID: 24752575
[TBL] [Abstract][Full Text] [Related]
12. A dual center study to compare breath volatile organic compounds from smokers and non-smokers with and without COPD.
Gaida A; Holz O; Nell C; Schuchardt S; Lavae-Mokhtari B; Kruse L; Boas U; Langejuergen J; Allers M; Zimmermann S; Vogelmeier C; Koczulla AR; Hohlfeld JM
J Breath Res; 2016 Apr; 10(2):026006. PubMed ID: 27082437
[TBL] [Abstract][Full Text] [Related]
13. Analysis of volatile organic compounds in the breath of patients with stable or acute exacerbation of chronic obstructive pulmonary disease.
Pizzini A; Filipiak W; Wille J; Ager C; Wiesenhofer H; Kubinec R; Blaško J; Tschurtschenthaler C; Mayhew CA; Weiss G; Bellmann-Weiler R
J Breath Res; 2018 Mar; 12(3):036002. PubMed ID: 29295966
[TBL] [Abstract][Full Text] [Related]
14. Confounding effect of benign pulmonary diseases in selecting volatile organic compounds as markers of lung cancer.
Wang M; Sheng J; Wu Q; Zou Y; Hu Y; Ying K; Wan H; Wang P
J Breath Res; 2018 Sep; 12(4):046013. PubMed ID: 30102249
[TBL] [Abstract][Full Text] [Related]
15. Breath markers for therapeutic radiation.
Salman D; Eddleston M; Darnley K; Nailon WH; McLaren DB; Hadjithelki A; Ruszkiewicz D; Langejuergen J; Alkhalifa Y; Phillips I; Thomas CLP
J Breath Res; 2020 Oct; 15(1):016004. PubMed ID: 33103660
[TBL] [Abstract][Full Text] [Related]
16. Volatile organic compounds in exhaled breath are independent of systemic inflammatory syndrome caused by intravenous lipopolysaccharide infusion in humans: results from an experiment in healthy volunteers.
Peters AL; Gerritsen MG; Brinkman P; Zwinderman KAH; Vlaar APJ; Bos LD
J Breath Res; 2017 Apr; 11(2):026003. PubMed ID: 28397711
[TBL] [Abstract][Full Text] [Related]
17. Pilot study of a breath test for volatile organic compounds associated with oral malodor: evidence for the role of oxidative stress.
Phillips M; Cataneo RN; Greenberg J; Munawar M; Nachnani S; Samtani S
Oral Dis; 2005; 11 Suppl 1():32-4. PubMed ID: 15752095
[TBL] [Abstract][Full Text] [Related]
18. Analysis of volatile organic compounds in exhaled breath by gas chromatography-mass spectrometry combined with chemometric analysis.
Dallinga JW; Smolinska A; van Schooten FJ
Methods Mol Biol; 2014; 1198():251-63. PubMed ID: 25270934
[TBL] [Abstract][Full Text] [Related]
19. Point-of-care breath test for biomarkers of active pulmonary tuberculosis.
Phillips M; Basa-Dalay V; Blais J; Bothamley G; Chaturvedi A; Modi KD; Pandya M; Natividad MP; Patel U; Ramraje NN; Schmitt P; Udwadia ZF
Tuberculosis (Edinb); 2012 Jul; 92(4):314-20. PubMed ID: 22647661
[TBL] [Abstract][Full Text] [Related]
20. Nonhuman primate breath volatile organic compounds associate with developmental programming and cardio-metabolic status.
Bishop AC; Libardoni M; Choudary A; Misra B; Lange K; Bernal J; Nijland M; Li C; Olivier M; Nathanielsz PW; Cox LA
J Breath Res; 2018 May; 12(3):036016. PubMed ID: 29593130
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
